EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays (Q36285345)

13 August 2017

EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays (English)

1 reference

13 August 2017

1 reference

4

1 reference

13 August 2017

Jared Allen

7

0 references

author name string

Caroline J Chapman

1

1 reference

13 August 2017

Graham F Healey

2

1 reference

13 August 2017

Andrea Murray

3

1 reference

13 August 2017

Chris Robertson

5

1 reference

13 August 2017

Laura J Peek

6

1 reference

13 August 2017

Alison J Thorpe

8

1 reference

13 August 2017

Geoffrey Hamilton-Fairley

9

1 reference

13 August 2017

Celine B Parsy-Kowalska

10

1 reference

13 August 2017

Isabel K MacDonald

11

1 reference

13 August 2017

William Jewell

12

1 reference

13 August 2017

Paul Maddison

13

1 reference

13 August 2017

John F R Robertson

14

1 reference

13 August 2017

11 April 2012

1 reference

13 August 2017

1 reference

13 August 2017

33

1 reference

13 August 2017

5

1 reference

13 August 2017

1319-1326

1 reference

Reduced lung-cancer mortality with low-dose computed tomographic screening

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Autoantibody signatures: progress and perspectives for early cancer detection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Melanoma-associated antigen genes - an update

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Clinical validation of an autoantibody test for lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Technical validation of an autoantibody test for lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Diverse molecular functions of Hu proteins

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Profiling tumor-associated antibodies for early detection of non-small cell lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

The RNA-binding protein HuD regulates neuronal cell identity and maturation.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

CT screening for lung cancer: five-year prospective experience

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Role of HuD and other RNA-binding proteins in neural development and plasticity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Early lung cancer action project: a summary of the findings on baseline screening

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Immunobiomarkers in small cell lung cancer: potential early cancer signals.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Low level anti-Hu reactivity: A risk marker for small cell lung cancer?

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Autoantibodies in lung cancer: possibilities for early detection and subsequent cure.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Two-step method to isolate target recombinant protein from co-purified bacterial contaminant SlyD after immobilised metal affinity chromatography.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

Inflammatory pathogenesis of prostate cancer and celecoxib

22 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS13277-012-0379-2

EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer

21 January 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460172

21 October 2018

https://api.crossref.org/works/10.1007%2FS13277-012-0379-2

A risk model for prediction of lung cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22492236

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-012-0379-2

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

22492236

1 reference